Current Topics in Medicinal Chemistry

Editor-in-Chief

Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA
(USA)

Personal Subscription
Become EABM
Become Reviewer



Epigenetic Regulation and Drug Discovery for Cancer Therapy free to download

Volume:19   Issue: 12
Pp: 971-971
Bin Yu and Liang Ouyang
DOI: 10.2174/156802661912190730153906



New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics

Volume:19   Issue: 12
Pp: 972-994
Yong-Tao Duan, Chetan B. Sangani*, Wei Liu, Kunjal V. Soni and Yongfang Yao*
DOI: 10.2174/1568026619666190603094439




Research Advances in the Use of Histone Deacetylase Inhibitors for Epigenetic Targeting of Cancer

Volume:19   Issue: 12
Pp: 995-1004
Yu Bai, Daid Ahmad, Ting Wang*, Guihua Cui and Wenliang Li*
DOI: 10.2174/1568026619666190125145110



An Overview of HDAC Inhibitors and their Synthetic Routes

Volume:19   Issue: 12
Pp: 1005-1040
Xiaopeng Peng, Guochao Liao, Pinghua Sun, Zhiqiang Yu and Jianjun Chen*
DOI: 10.2174/1568026619666190227221507




Recent Study of Dual HDAC/PARP Inhibitor for the Treatment of Tumor

Volume:19   Issue: 12
Pp: 1041-1050
Haiying Lu, Lan Bai, Yanping Zhou, Yongping Lu, Zhongliang Jiang* and Jianyou Shi*
DOI: 10.2174/1568026619666190603092407




Recent Progress on the Discovery of Sirt2 Inhibitors for the Treatment of Various Cancers

Volume:19   Issue: 12
Pp: 1051-1058
Ting Wang, Zhuyu Xu, Yongping Lu, Jianyou Shi, Wenbo Liu, Chengchen Zhang, Zhongliang Jiang, Baowen Qi* and Lan Bai*
DOI: 10.2174/1568026619666190510103416




Pharmaceutical Inhibition of Neddylation as Promising Treatments for Various Cancers

Volume:19   Issue: 12
Pp: 1059-1069
Lina Yin, Yuanyuan Xue, Qiannan Shang, Haichao Zhu, Meihua Liu, Yingxiang Liu and Qingzhong Hu*
DOI: 10.2174/1568026619666190311110646